Article Sidebar

PDF
Date Published: 08/01/2022
Abstract Views: 382
Views PDF: 298
DOI: https://doi.org/10.51298/vmj.v508i2.1609
Issue
Vol. 508 No. 2 (2021)
Section
Các bài báo
How to Cite
Thị Anh Đào, L. ., & Thị Hằng, N. . (2022). CLINICAL FEATURES OF UNEXPLAINED RECURRENT PREGNANCY LOSS WOMEN CARRYING ABNORMAL MTHFR POLYMORPHISM GENE. Vietnam Medical Journal, 508(2). https://doi.org/10.51298/vmj.v508i2.1609

CLINICAL FEATURES OF UNEXPLAINED RECURRENT PREGNANCY LOSS WOMEN CARRYING ABNORMAL MTHFR POLYMORPHISM GENE

Lê Thị Anh Đào1,, Nguyễn Thị Hằng2
1 Hanoi Medical University
2 Vinmec Times City International Hospital

Main Article Content

Abstract

Unexplained RPL has been a challenging issue in diagnosis. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms (C677T, A1298C) are believed to be risk of unexplained recurrent pregnancy loss. This study aims to describe the clinical signs of women with recurrent pregnancy loss and MTHFR polymorphism gene. This is a case-control study was performed on 2 groups. Both two groups were evaluated for the presence of MTHFR gene polymorphisms by PCR technique. Result: A total of 43 cases and 30 controls were identified. The gene carrying group had earlier miscarriage time in the history 8.47 weeks. MTHFR C677T polymorphism gene was increased the risk of miscarriage symptoms in the first trimester (abdominal pain: OR=5.6, 95%CI: 1.1-28.6, p=0.038, vaginal bleeding: OR=3.6, 95%CI: 1.0-12.5, p=0.043). Conclusion: MTHFR C677T gene polymorphism is associated with increased risk of URPL in Vietnamese women and miscarriage symptoms in the first trimester.

Article Details

Keywords

MTHFR C677T, MTHFR A1298C, polymorphism, Unexplained recurrent pregnancy loss

References

1. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and Sterility. 2012; vol. 98, (5), pp. 1103-1111.
2. Balasubramaniam, Kotalawala, Amarasekara. Analysis of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms (C677t & A1298c) in Recurrent Pregnancy Loss (RPL). Nessa Journal of Gynecology.2017; vol. 1, no. 4, pp. 1-26, 2017.
3. Đỗ Tiến Dũng. Huyết khối và sảy thai liên tiếp. Tạp chí Y học lâm sàng Bệnh viện Bạch Mai. 2010; vol. 50, pp. 12-16.
4. Barut MU, Bozkurt M, Kahraman M. Thrombophilia and Recurrent Pregnancy Loss: The Enigma Continues. Medical Science Monitor 2018; vol. 24, pp. 4288-4294.
5. SC Liew; ED Gupta, "Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: Epidemiology, metabolism and the associated diseases," European Journal of Medical Genetics. 2015; vol. 58, pp. 1-10.
6. Vandana Rai. Methylenetetrahydrofolate Reductase C677T Polymorphism and Recurrent Pregnancy Loss Risk in Asian Population: A Meta-analysis. Indian Journal of Clinical Biochemistry. 2016; vol. 31, no. 4, pp. 402-413.
7. Tranquilli AL, Saccucci F, Giannubilo SR. Unexplained fetal loss: the fetal side of thrombophilia. Fertility and Sterility 2010; vol. 94, no. 378-380.
8. Liew S, Gupta E. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: Epidemiology, metabolism and the associated diseases. European Journal of Medical Genetics. 2015; vol. 58, pp. 1-10, 2015.
9 Ananth C, Peltier M, Marco C, et al. Associations between 2 polymorphisms in the methylenetetrahydrofolate reductase gene and placental abruption. American Journal of Obstetrics and Gynecology. 2007; vol. 197, no. 4, p. 385.